5432522026-04-012026-06-305432522026-04-012026-06-30in-capmkt:OtherExpenses1Member5432522026-04-012026-06-30in-capmkt:OtherExpenses2Member5432522026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15432522026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25432522026-04-012026-06-30AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares543252FAIRCHEMORNOTLISTEDINE0DNW01011Fairchem Organics LimitedMain BoardEquity2026-04-012027-03-312026-07-272026-07-13INRLakhsQuarterlyFirst quarterSingle segmentSpeciality Chemicals2026-07-2711:40:002026-07-2712:35:00Declaration of unmodified opinionfalsefalseNot applicable2026-04-012026-06-30UnauditedStandalone1761457000347500017649320001202654000015981000067540000183790002740000015278200016285650001363670000136367000359790002500003622900001001380000000100138000-383700096301000125959000107.957.95007.957.95000 <br /> Notes: <br /> 1. The above unaudited financial results, as reviewed by Audit Committee, are subsequently approved by the Board of Directors at their meetings held on July 27, 2026. The Statutory Auditors have performed limited review of the Company's financial results for the quarter ended June 30, 2026. The Statutory Auditors have expressed an unmodified review conclusion. <br /> <br /> 2. The unaudited financial results of the Company have been prepared in accordance with Indian Accounting Standards (‘Ind AS’) prescribed under Section 133 of the Companies Act, 2013 read with the relevant rules issued thereunder and in terms of the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. <br /> <br /> 3. The figures for the quarter ended March 31, 2026 are the balancing figures between the audited figures in respect of the full financial year and the year to date unaudited figures up to the third quarter for that year. Also, the figures up to the end of third quarter had only been reviewed and not subjected to audit. <br /> <br /> 4. The Company is engaged in the business of manufacturing of speciality chemicals viz. Oleo Chemicals and Intermediate Nutraceuticals. Considering the nature of Company’s business, as well as based on review of operating results by the chief operating decision maker to make decisions about resource allocation and performance measurement, there is only one reportable business segment in accordance with the requirements of IND AS 108 – “Operating Segments”. As almost all the revenue of the Company is from domestic sales, no separate geographical segment is disclosed. <br /> (Rs. In Lakhs) <br /> <br /> Particulars Quarter ended Year ended <br /> 30-June-2026 31-Mar-2026 30-June-2025 31-Mar-2026 <br /> Unaudited Audited Unaudited Audited <br /> I Segment Revenue <br /> Speciality Chemicals 17,614.57 11,692.84 13,106.31 45,964.82 <br /> <br /> II Segment Results <br /> Speciality Chemicals 1,547.46 552.40 261.68 1,153.96 <br /> Less: Finance cost (183.79) (112.01) (100.52) (369.66) <br /> Add: Interest Income - 32.81 0.40 35.98 <br /> Profit Before Tax and Exceptional Items 1,363.67 473.19 161.56 820.27 <br /> Less: Exceptional Items (Note 6) - - - (88.27) <br /> Profit Before Tax 1,363.67 473.19 161.56 732.00 <br /> <br /> III Segment Assets <br /> Speciality Chemicals 39,751.56 39,097.93 36,189.52 39,097.93 <br /> <br /> IV Segment Liabilities <br /> Speciality Chemicals 12,484.50 12,793.90 5,875.54 12,793.90 <br /> <br /> 5. The Company does not have any subsidiary/associate/joint venture company as on June 30, 2026. <br /> <br /> 6. The Government of India has implemented four new Labour Codes, including the Codes on Wages,2019 w.e.f. November 21, 2025. Based on management’s assessment, actuarial valuation and in line with ICAI guidance, the Company has recognised additional employee benefit obligation of Rs.88.27 Lakhs and considering the event as regulatory-driven and nonrecurring in nature, the impact of the same has been disclosed under exceptional items in the financial results for the year ended 31 March 2026. <br /> <br /> 7. The Board of Directors at its meeting held on November 20, 2025 passed a resolution to buyback upto 4,25,000 Equity Shares of Rs. 10/- each fully paid-up, representing 3.26% of the total number of pre-buyback equity shares of the Company as at March 31, 2025, through a Tender Offer route, at a price of Rs. 800/- (Rupees Eight Hundred only), payable in cash, for an aggregate amount not exceeding Rs. 34 Crores, excluding any expenses or transaction costs incurred or to be incurred for the Buyback. Thereafter, the Members of the Company through Postal Ballot approved the Special Resolution on December 26, 2025. Accordingly, the Buyback offer was commenced on January 8, 2026 and closed on January 14, 2026. <br /> Pursuant to and in compliance with the provisions of Section 68 of the Companies Act, 2013 read with Rule 17 of the Companies (Share Capital and Debentures) Rules, 2014 and the Securities and Exchange Board of India (Buyback of Securities) Regulations, 2018, the settlement of all valid bids was completed on January 21, 2026 and 4,25,000 Equity Shares, which were tendered and accepted in Buyback were extinguished on January 27, 2026. <br /> <br /> 8. Investors can view the unaudited financial results of the company for the quarter ended June 30, 2026 on the company's website www.fairchem.in, on the website of the BSE www.bseindia.com and on the website of NSE www.nseindia.com. <br /> <br /> <br /> For and on behalf of the Board of Directors, <br /> For, Fairchem Organics Limited <br /> <br /> <br /> Place: Chekhala, Taluka Sanand, Dist. AHMEDABAD Nahoosh Jariwala <br /> Date: July 27, 2026 Chairman and Managing Director <br /> (DIN: 00012412) <br /> <br /> <br /> Power and Fuel69815000Other Expenses82967000Remeasurement (losses)/Gains on Post Employment Defined Benefit Plans-5128000Income Tax effect1291000-38370000-3837000UnauditedtrueB S R and Cotrue2029-04-30